Moxibustion as an Adjuvant Therapy for Chronic Kidney Disease: A Systematic Review and Meta‐Analysis of 23 Randomized Controlled Trials
Open Access
- 1 January 2020
- journal article
- review article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 6128673
Abstract
Objective. This systematic review aims to investigate the efficacy and safety of moxibustion for chronic kidney disease (CKD). Methods. Nine databases were searched to identify relevant evidence up to March 8, 2020. Randomized controlled trials (RCTs) that tested moxibustion + basic treatments versus basic treatments alone for patients with CKD and reported, at least, one of the outcomes of interest were included. In the meta‐analyses, the mean differences (MDs) and 95% confidence intervals (CIs) were used to measure the effect size. Results. Twenty‐three RCTs (n = 1571) with a moderate to high risk of bias were included. The pooled estimates showed that compared with the controls, patients after moxibustion had a significant reduction in serum creatinine (MD −17.34 μmol/L, 95% CI −28.44 to −6.23; I2 = 87%), 24‐hour urine protein excretion (MD −0.75 g/h, 95% CI −1.07 to −0.42; I2 = 84%), and blood urea nitrogen (MD −0.63 mmol/L, 95% CI −1.09 to −0.18; I2 = 37%) and a significant improvement in the quality of life (MD 10.18, 95% CI 3.67 to 16.69; I2 = 57%). Moxibustion did not show a significant effect on the estimated glomerular filtration rate (eGFR), creatinine clearance, or hemoglobin. The subgroup analyses showed that a longer course of moxibustion (>8 weeks) and indirect moxibustion had a greater effect on reducing serum creatinine. The effect of moxibustion on blood urea nitrogen changed to be nonsignificant after excluding RCTs with a high risk of bias (MD −0.96 mmol/L, 95% CI −2.96 to 1.03). Only one adverse event of burn was reported. Conclusions. This systematic review suggests that, as an adjuvant therapy, moxibustion may improve serum creatinine, urinary protein excretion, blood urea nitrogen, and quality of life in patients with CKD. Moxibustion may not have effects on eGFR, creatinine clearance, or hemoglobin. The quality of evidence is weakened by the limitations of risk of bias, heterogeneity, and imprecision.Keywords
Funding Information
- National Natural Science Foundation of China (81904057)
- Education Department of Jiangxi Province (GJJ180696)
- Jiangxi University of Traditional Chinese Medicine (5142001011)
This publication has 44 references indexed in Scilit:
- How Does Moxibustion Possibly Work?Evidence-Based Complementary and Alternative Medicine, 2013
- GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)Journal of Clinical Epidemiology, 2011
- Renal Association Clinical Practice Guideline in Mineral and Bone Disorders in CKDNephron Clinical Practice, 2011
- Adverse events of moxibustion: A systematic reviewComplementary Therapies in Medicine, 2010
- Electroacupuncture and Moxibustion Attenuate the Progression of Renal Disease in 5/6 Nephrectomized RatsKidney and Blood Pressure Research, 2008
- Hemoglobin Decline in Children with Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2008
- Moxibustion burnsJournal of Hospital Medicine, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Serum Creatinine and Renal FunctionAnnual Review of Medicine, 1988
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986